BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Announce Breast Cancer Immunotherapy Findings at Key Oncology Conferences
BriaCell Therapeutics Corp. will reveal important information about Bria-IMT and Bria-OTS at two leading conferences – the ASCO-SITC Clinical Immuno-Oncology Symposium and the American Association of Cancer Research’s annual meeting New information will also be made available about the company’s HLA-identification test, BriaDX, which is aimed at identifying patients most likely to benefit from Bria-IMT In addition, BriaCell founder and director Dr. Charles L. Wiseman will be a keynote speaker at the 10th Euro Breast Cancer Summit in France BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company with a focus on immune-oncology, is expected to announce findings pertaining…